Lupin Limited (LUPIN.NS)

1.679,65 +24,90 (+1,50%) Börsenschluss: 03:30PM IST

Lupin Limited

Kalpataru Inspire
3rd Floor Off. Western Expressway Highway Santacruz (East)
Mumbai 400055
India
91 22 6640 2323
https://www.lupin.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 20.933

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Ms. Vinita D. Gupta	CEO & Executive Director	109,2M	N/A	1968
Mr. Ramesh Swaminathan	Global CFO, CRO, Head of Corporate Affairs & Executive Director	66,86M	N/A	1966
Mr. Nilesh Deshbandhu Gupta	MD & Executive Director	49,6M	N/A	N/A
Mr. Johnny Mack Mikell	President & Global Head of Quality	N/A	N/A	N/A
Mr. Christoph Funke	Chief Technical Operations Officer	N/A	N/A	N/A
Mr. Sreeji Gopinathan	Chief Information Officer	N/A	N/A	N/A
Dr. Shahin Fesharaki	Global Chief Scientific Officer	N/A	N/A	N/A
Dr. Hemant Bakhru	Vice President of Investor Relations and M&A	N/A	N/A	N/A
Dr. Sofia Mumtaz	President of Legal and Compliance of Australia, Japan & Canada Business	N/A	N/A	N/A
Ms. Diana Amador-Toro	Senior Vice President of Global Compliance	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in INR.

Beschreibung

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilars; over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Corporate Governance

Lupin Limiteds ISS Governance QualityScore, Stand 1. Mai 2024, lautet 9. Die grundlegenden Scores sind Audit: 10, Vorstand: 4, Shareholderrechte: 1, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.